CombiMatrix said today that it will provide miscarriage analysis to American Pathology Partners' (AP2) physician customers using its chromosomal microarray analysis platform.

AP2 is a nationwide network of anatomic pathology laboratories with a focus on women's health. CombiMatrix said it has commenced working with Denver-based UniPath, AP2's flagship lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.